Pet industry M&A picks up again across food, services, and supply
The pet industry is seeing another burst of merger and acquisition activity this winter, with deals stretching from premium food brands to distribution and pet care platforms. GlobalPETS highlighted a fresh round of transactions involving players such as AlphaPet, Covetrus, and Rover, underscoring how strategic buyers and private equity-backed companies are still using acquisitions to build scale, enter new geographies, and deepen category reach. Recent developments suggest the momentum is especially strong in premium nutrition, veterinary supply infrastructure, and tech-enabled services. (ad-hoc-news.de)
The backdrop is a pet market that has stayed attractive even as broader dealmaking has been uneven. GlobalPETS reported that, in the first nine months of 2025, pet industry M&A remained active despite a softer overall M&A environment, with a fragmented mix of mostly smaller transactions aimed at geographic and portfolio expansion. Nearly half of the deals it analyzed were in pet food, especially premium and fresh formats, while veterinary services, pet health, and pharmaceuticals also drew attention. That pattern fits a longer-running thesis: pet parents continue to spend on higher-quality food, wellness, and care, even when budgets are under pressure. (globalpetindustry.com)
One of the clearest current examples is AlphaPet Ventures’ acquisition of Cpro Food, announced March 27, 2026. AlphaPet said the Belgian brand gives it access to a market with one of Europe’s highest premium shares and extends its “local hero” strategy in super-premium dog and cat food. The company described Cpro as a leading Belgian super-premium brand with distribution through specialty pet retailers and breeders, and said the deal is its fifth acquisition since 2020. That follows AlphaPet’s earlier moves in Germany and the UK, showing how regional premium brands remain attractive targets for platforms trying to assemble broader European portfolios. (ad-hoc-news.de)
In services, Rover remains a key example of how financial sponsors are trying to scale pet care platforms after Blackstone completed its $2.3 billion acquisition in February 2024. Since then, Rover has continued to pursue international expansion, including its move into Australia through Mad Paws and its earlier European expansion efforts. In distribution and animal health, Covetrus is now tied to another significant combination: Covetrus and MWI Animal Health announced a merger that the companies say would broaden reach across veterinarians, producers, and manufacturers, though the transaction is still subject to regulatory approval and is not expected to close within Cencora’s fiscal 2026 ending September 30, 2026. (blackstone.com)
Industry commentary helps explain why buyers are still active. In GlobalPETS’ reporting, Houlihan Lokey’s Garyth Stone said the sector’s “strong” fundamentals are the main driver, especially increased spend per pet rather than simply more pets. NielsenIQ’s Andrea Binder pointed to heavy interest in science-backed categories such as supplements, where buyers may prefer acquiring proven brands instead of building clinical credibility from scratch. Those comments line up with broader market data from S&P Global Market Intelligence, which found private equity and venture capital investment in the pet sector surged in 2023, supported by demand for premium, sustainable, and specialized products and services. (globalpetindustry.com)
Why it matters: For veterinary professionals, consolidation in adjacent pet sectors can have practical effects well beyond headline deal values. Distribution mergers can alter purchasing channels, service levels, and negotiating dynamics for clinics. Acquisitions in premium nutrition and supplements can influence the products pet parents ask about in exam rooms, while pet services platform expansion may affect continuity of care, referral patterns, and client expectations around convenience and digital access. If larger platforms keep pairing commerce, logistics, and consumer-facing services, veterinary teams may increasingly find themselves operating in a market where fewer companies control more of the pet care journey. (covetrus.com)
There’s also a strategic signal in where the deals are clustering. Premium food remains the most active lane, but the combination of veterinary distribution, health products, and service marketplaces suggests investors still see value in businesses that can capture recurring spend and build direct relationships with pet parents. For clinics, that could mean more competition from scaled consumer brands in some categories, but also more partnership opportunities in others, especially where compliance, home delivery, diagnostics, or chronic-condition support are involved. This is less about one blockbuster acquisition than about a steady reordering of the ecosystem around convenience, premiumization, and scale. (globalpetindustry.com)
What to watch: The next signals will be whether the Covetrus-MWI transaction secures approvals on expected terms, whether more European premium food brands are absorbed into larger portfolios, and whether the larger processes expected in late 2025 and early 2026 translate into stronger valuations and a more sustained M&A cycle across animal health and pet care. (covetrus.com)